zidovudine

FDA Drug Profile — RETROVIR

zidovudine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including RETROVIR. Available dosage forms: capsule, solution, injection, solution.

Drug Details

Generic Name
zidovudine
Brand Names
RETROVIR
Application Number
NDA019655
Sponsor
ViiV Healthcare Company
NDC Codes
3
Dosage Forms
CAPSULE, SOLUTION, INJECTION, SOLUTION
Routes
ORAL, INTRAVENOUS
Active Ingredients
ZIDOVUDINE

Indications and Usage

1 INDICATIONS AND USAGE Lamivudine and zidovudine tablets a combination of 2 nucleoside analogues, are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Lamivudine and zidovudine tablets, a combination of 2 nucleoside analogue reverse transcriptase inibitors, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.